Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio 0.00 0.00 0.00 200.70 71.65 281.07 130.38 87.30 52.90 30.87
P/S ratio 8.49 6.97 10.24 13.50 18.11 21.21 15.35 13.12 7.59 5.56
P/FCF ratio 9,737.73 192.52 188.35 148.17 126.15 19.10 146.62 92.82 48.53 24.04
P/Operating CF 366.08 121.49 313.54 138.69 202.86 490.90 337.18 355.63 101.56 88.09
P/B ratio 17.16 11.93 15.93 22.58 19.10 25.43 20.96 22.97 14.56 9.43
Price to Tangible BV 17.87 12.29 16.39 23.07 19.54 26.18 23.11 24.89 15.49 9.77
EV/Sales 8.28 6.66 9.88 13.19 17.58 20.92 15.19 13.08 7.29 5.42
EV/EBITDA 0.00 0.00 0.00 101.93 92.39 139.25 80.77 60.44 35.97 21.73
EV/Operating CF 84.47 52.02 82.73 61.91 71.21 115.74 66.00 63.28 29.73 17.55
EV/FCF 9,494.53 184.08 181.69 144.75 122.45 18.83 145.03 92.53 46.64 23.47
Quick Ratio 2.20 4.92 7.25 5.05 5.11 4.50 1.72 2.38 1.22 1.50
Current Ratio 2.73 5.36 7.64 5.47 5.58 5.11 1.99 2.84 1.47 1.88
Net Debt/EBITDA 2.41 8.37 2.39 (2.41) (2.79) (1.98) (0.89) (0.37) (1.64) (0.65)
Debt/Assets 1.49% 36.23% 52.73% 44.83% 39.25% 40.60% 36.54% 38.86% 19.08% 19.57%
Debt/Equity 0.02 0.78 1.52 1.22 0.92 0.98 0.92 1.18 0.59 0.45
Asset Turnover 1.65 1.10 0.73 0.68 0.58 0.53 0.56 0.62 0.63 0.73
Operating CF/Net income (0.86) (1.83) (0.97) 3.11 0.87 2.04 1.96 1.38 1.72 1.72
Capex/Depreciation (3.71) (4.10) (2.31) (3.70) (2.97) 22.32 (2.34) (1.27) (1.65) (1.44)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE (25.98%) (14.28%) (23.48%) 13.08% 40.58% 11.21% 16.35% 25.78% 27.63% 34.50%
ROA (18.88%) (7.68%) (9.01%) 4.69% 16.44% 4.70% 6.61% 9.29% 9.04% 13.04%
ROIC (24.04%) (13.39%) (40.43%) 21.03% 23.31% 12.65% 14.86% 21.00% 49.33% 28.66%
Return on Tangible Assets (22.86%) (6.68%) (7.66%) 5.24% 16.53% 5.76% 11.83% 13.60% 21.27% 24.24%
Average Days of Receivables 64.75 68.22 80.21 70.80 81.18 76.67 89.48 98.13 91.02 95.21
Research and Development Expense of Revenue 27.23% 25.80% 40.46% 18.53% 18.68% 24.68% 16.64% 13.96% 13.70% 12.85%
Selling, General and Administrative Expense of Revenue 49.92% 48.60% 41.95% 34.94% 32.09% 33.10% 34.63% 32.73% 31.88% 27.69%
Intangible Assets out of Total Assets 0.03 0.01 0.01 0.01 0.01 0.01 0.04 0.03 0.02 0.02
Share Based Compensation of Revenue 19.33% 14.78% 9.88% 6.96% 6.20% 4.63% 4.35% 4.16% 4.23% 3.42%
Graham Net Nets 0.03 0.05 0.04 0.02 0.03 0.02 0.01 0.00 0.00 0.02
Graham Number 0.00 0.00 0.00 3.85 11.85 7.53 10.41 13.04 13.29 18.45
Earnings Yield (1.34%) (1.02%) (1.20%) 0.50% 1.40% 0.36% 0.77% 1.15% 1.89% 3.24%
Free Cash Flow Yield 0.01% 0.52% 0.53% 0.67% 0.79% 5.24% 0.68% 1.08% 2.06% 4.16%
Revenue per Share 1.71 2.08 2.92 4.05 5.10 6.33 7.47 9.38 10.25 11.95
Operating CF per Share 0.17 0.27 0.35 0.86 1.26 1.14 1.72 1.94 2.51 3.69
Capex per Share (0.17) (0.19) (0.19) (0.49) (0.53) 5.89 (0.94) (0.61) (0.91) (0.93)
Free Cash Flow per Share 0.00 0.08 0.16 0.37 0.73 7.03 0.78 1.33 1.60 2.76
Cash per Share 0.37 1.59 3.93 4.21 7.17 7.06 6.31 7.06 6.55 5.12
Shareholders Equity per Share 0.85 1.21 1.88 2.42 4.84 5.28 5.47 5.36 5.34 7.04
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 0.85 1.21 1.88 2.42 4.84 5.28 5.47 5.36 5.34 7.04
Free Cash Flow 0.50 26.00 56.10 134.50 276.60 2,719.60 304.70 511.90 630.70 1,077.20
Working Capital 177.60 605.80 1,477.10 1,609.20 2,810.70 2,963.60 1,829.50 2,869.90 1,369.40 1,890.80
Capital Expenditures (55.70) (66.00) (67.10) (180.00) (199.00) 2,277.10 (364.80) (236.60) (358.80) (363.50)
Net Current Asset Value 161.00 260.00 446.80 457.00 960.80 793.20 408.90 230.00 (80.50) 439.40
EV/EBIT 0.00 0.00 0.00 136.82 113.08 192.68 112.96 79.25 49.02 27.73
Capex to Sales 0.10 0.09 0.07 0.12 0.10 (0.93) 0.13 0.07 0.09 0.08
Net Profit Margin (11.44%) (6.99%) (12.32%) 6.85% 28.53% 8.86% 11.73% 14.95% 14.29% 17.94%
Price to Operating Income 0.00 0.00 0.00 140.05 116.50 195.40 114.20 79.49 51.02 28.40
Other line items
Depreciation/Fixed assets 0.14 0.11 0.16 0.15 0.13 0.13 0.15 0.17 0.16 0.16
Cash ROIC (12.87%) (4.14%) (1.96%) (0.19%) (0.64%) (5.30%) (5.89%) (5.05%) (5.92%) (1.99%)
Accounts Receivable Turnover 6.52 6.09 5.72 5.75 5.39 5.19 4.74 4.29 4.07 4.20
Accounts Payable Turnover 3.64 2.92 3.14 2.70 1.75 1.46 1.39 1.19 1.09 1.05
Inventory Turnover 4.84 5.00 6.35 5.72 3.65 2.59 3.09 3.08 2.89 3.18
Average Days of Payables 127.53 140.58 146.02 171.88 271.58 272.32 320.60 368.31 362.78 381.46
Days of Inventory on Hand 85.02 72.87 70.18 80.31 132.49 169.81 109.03 153.18 124.18 123.45
Average Receivables 87.90 118.00 180.50 256.50 357.40 471.40 613.80 843.60 989.80 1,110.90
Average Payables 53.50 77.65 117.15 201.75 368.75 527.05 737.40 1,123.65 1,465.30 1,764.55
Average Inventory 40.30 45.30 57.95 95.25 177.25 296.00 332.00 433.15 551.10 585.85
Average Assets 347.40 653.45 1,410.05 2,155.50 3,342.75 4,611.90 5,162.50 5,828.10 6,374.50 6,412.20
Average Common Equity 252.50 351.60 541.35 772.95 1,354.55 1,934.30 2,086.95 2,100.20 2,085.60 2,424.30

Fold the line items

Columns are period end dates